The U.S. regulatory system involves the public in the decision-making process. Lastly, the agencies have been open to modifying their regulations based on experience with technology and scientific advancements. It should be noted that extensive scientific evaluations by USDA, EPA and FDA have identified no significant or unexpected concerns unique to products resulting from biotechnology. FDA has conducted public sessions on various aspects of biotech foods and received tens of thousands of written comments. The Secretary formed this committee not because of concerns about products currently on the market, but to ensure that USDA is fully prepared for the future.
Biotechnology is a tool.
Like any tool, if used properly and with care, it can be safe and beneficial. Many of the concerns that have arisen regarding biotechnology stem from concerns about its potential uses. The U.S. regulatory system ensures that products that are commercially grown, sold, processed, and consumed are safe. We recognize the right of every country to establish its own product evaluation system. However, we believe that such regulatory decisions must be open to public comment, predictable, and based on science.